phosphorylethanolamine has been researched along with Fatty Liver, Nonalcoholic in 3 studies
phosphorylethanolamine: RN given refers to parent cpd; structure
O-phosphoethanolamine : The ethanolamine mono-ester of phosphoric acid, and a metabolite of phospholipid metabolism. This phosphomonoester shows strong structural similarity to the inhibitory neurotransmitter GABA, and is decreased in post-mortem Alzheimer's disease brain.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Compared to controls, both NAFLD groups had increased PDE/TP (p<0." | 5.40 | Non-alcoholic fatty liver disease: spectral patterns observed from an in vivo phosphorus magnetic resonance spectroscopy study. ( Abrigo, JM; Chan, AW; Chan, FK; Chan, HL; Chim, AM; Choi, PC; Chu, WC; Shen, J; Wong, GL; Wong, VW; Yeung, DK, 2014) |
| "Compared to controls, both NAFLD groups had increased PDE/TP (p<0." | 1.40 | Non-alcoholic fatty liver disease: spectral patterns observed from an in vivo phosphorus magnetic resonance spectroscopy study. ( Abrigo, JM; Chan, AW; Chan, FK; Chan, HL; Chim, AM; Choi, PC; Chu, WC; Shen, J; Wong, GL; Wong, VW; Yeung, DK, 2014) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Grapentine, S | 1 |
| Singh, RK | 1 |
| Basu, P | 1 |
| Sivanesan, S | 1 |
| Mattos, G | 1 |
| Oresajo, O | 1 |
| Cheema, J | 1 |
| Demeke, W | 1 |
| Dolinsky, VW | 1 |
| Bakovic, M | 1 |
| Abrigo, JM | 1 |
| Shen, J | 1 |
| Wong, VW | 1 |
| Yeung, DK | 1 |
| Wong, GL | 1 |
| Chim, AM | 1 |
| Chan, AW | 1 |
| Choi, PC | 1 |
| Chan, FK | 1 |
| Chan, HL | 1 |
| Chu, WC | 1 |
| Jeon, MJ | 1 |
| Lee, Y | 1 |
| Ahn, S | 1 |
| Lee, C | 1 |
| Kim, OH | 1 |
| Oh, BC | 1 |
| Yu, U | 1 |
| Kim, H | 1 |
3 other studies available for phosphorylethanolamine and Fatty Liver, Nonalcoholic
| Article | Year |
|---|---|
Pcyt2 deficiency causes age-dependant development of nonalcoholic steatohepatitis and insulin resistance that could be attenuated with phosphoethanolamine.
Topics: Aging; Animals; Ethanolamines; Fatty Acids; Glucose; Insulin Resistance; Mice; Mice, Knockout; Non-a | 2022 |
Non-alcoholic fatty liver disease: spectral patterns observed from an in vivo phosphorus magnetic resonance spectroscopy study.
Topics: Adult; Case-Control Studies; Ethanolamines; Female; Glycerylphosphorylcholine; Humans; Magnetic Reso | 2014 |
High resolution in vivo 31P-MRS of the liver: potential advantages in the assessment of non-alcoholic fatty liver disease.
Topics: Animals; Disease Models, Animal; Ethanolamines; Glycerylphosphorylcholine; Liver Cirrhosis; Magnetic | 2015 |